Clinical Trial

Quality of Life and Cognitive Functioning in Patients With Glial Tumors

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to introduce appropriate assessment instruments and to define patients with gliomas according to cognitive functioning and quality of life. The study will evaluate cognitive functioning as a prognostic factor for survival in patients with glial tumors and will support optimization of treatment strategies to improve patients' quality of life.
Trial Details
NCT Number NCT07416838
Lead Sponsor Institute of Oncology Ljubljana
Conditions Glial Tumors
Enrollment 90 participants
Start Date 2018-09-21
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-18